Document is current
Any future updates will be listed below
-
Authors
Tal, Michael G. https://orcid.org/0000-0002-2642-4296
Keidar, Ran
Magnazi, Gilad
Henn, Ohad
Kim, Jin Hee
Chudnoff, Scott G.
Stepp, Kevin J.
-
Funding
Funding for this research was provided by:
Empress Medical Ltd.
- License Information
-
More Information
Article History
Received: 24 February 2022
Accepted: 4 July 2022
First Online: 8 August 2022
Declarations
:
: Ethics Committee approval letters were provided by the Comite de Etica de Investigacion, Clinical Canela (La Romana, Dominican Republic) on 18 July 2019 separately, both in Spanish (Original) and English (Translation).
: Informed consent was obtained from all individuals participating in the study.
: Not applicable.
: MG Tal, R Keidar, G Magnazi, O Henn, and KJ Stepp declared having equity in Empress Medical, which developed and manufactured the Empress Fibroid Treatment System.
